期刊文献+

苦黄注射液Ⅲ期临床试验 被引量:16

A Ⅲ-Phase Clinical Trial for Kuhuang Injection
暂未订购
导出
摘要 采用苦黄注射液治疗各型病毒性肝炎555例,并设对照组(150例)进行观察。经2~6周治疗,急性黄疸型肝炎(AIH)临床症状改善,退黄和降酶疗效较对照组疗效快且好;对慢性活动性肝炎(CAH)也有较好的退黄和降酶疗效;对瘀胆型肝炎(CSH)、亚急性重型肝炎(SHG)、慢性重型肝炎(CHG)及肝炎肝硬化(PHC)的治疗,也提示有一定的退黄和降酶作用。按中医辨证,热偏重型和湿偏重型均有退黄和降酶效果,以热偏重型疗效较好。 Five hundred and fifty-five cases of various types of viral hepatitis were treated byKuhuang Injection(KI)and 150 cases as control.After treatment for 2 to 6 weeks, the effects of relievingsymptoms,reducing jaundice and lowering transaminase for acute icteric hepatitis were more prominentin the group treated by KI than in the control group. These effects were also shown in chronic active hep-atitis and more or less in cholestatic hepatitis,severe subacute and chronic hepatitis and posthepatitic cir-rhosis.As to the syndrome differentiation based on traditional Chinese medicine,the jaundice reducingand transaminase lowering effects were also observed in the cases with predominant heat syndrome andthose with predominant dampness syndrome,especially the former.
出处 《中药新药与临床药理》 CAS CSCD 1996年第1期7-11,共5页 Traditional Chinese Drug Research and Clinical Pharmacology
关键词 中药 苦黄注射液 治疗应用 方剂 Kuhuang Injection/therapeutic use hepatitis,viral,human/therapy,TCM
  • 相关文献

同被引文献113

引证文献16

二级引证文献71

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部